Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 2,181 - 2,200 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((we decrease) OR (mean decrease)) ))', query time: 0.62s Refine Results
  1. 2181
    IFA reduced the capsular biosynthesis through altering bacterial metabolism.

    IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2182
    IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule.

    IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2183
    IFA disarmed capsule-mediated immune evasion.

    IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2184
    IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>.

    IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2185
    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>.

    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 2186
    IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule.

    IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2187
    Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant.

    Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2188
    Schematic diagram summarizing the overall mechanism of action.

    Schematic diagram summarizing the overall mechanism of action. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2189
    Effects of PCM7−4 on the relative expression of genes associated with biofilm formation.

    Effects of PCM7−4 on the relative expression of genes associated with biofilm formation. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2190
    Effects of bacteriocin PCM7−4 on bacteria within the biofilm in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on bacteria within the biofilm in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2191
    The impact of bacteriocin PCM7−4 on the formation of <i>L. monocytogenes</i> biofilms was observed using SEM.

    The impact of bacteriocin PCM7−4 on the formation of <i>L. monocytogenes</i> biofilms was observed using SEM. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2192
    List of primers used in this study.

    List of primers used in this study. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2193
    Effects of bacteriocin PCM7−4 on the quantification of biofilm formation in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on the quantification of biofilm formation in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2194
    Effects of bacteriocin PCM7−4 on motility in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on motility in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2195
    Effects of bacteriocin PCM7−4 on the exopolysaccharide production in <i>L. monocytogenes.</i>

    Effects of bacteriocin PCM7−4 on the exopolysaccharide production in <i>L. monocytogenes.</i> by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2196
    Growth curve of L. monocytogenes exposed to bacteriocin PCM7−4.

    Growth curve of L. monocytogenes exposed to bacteriocin PCM7−4. by Haotian Ma (11100492)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2197
    Location, timing, and size of the European outbreaks.

    Location, timing, and size of the European outbreaks. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 2198
    Overview of the parameters used in the model.

    Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 2199
    SEIR model structure for humans and mosquitoes.

    SEIR model structure for humans and mosquitoes. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2200
    Coverage curve scenario analysis showing the number of infections at various vaccination coverage rates.

    Coverage curve scenario analysis showing the number of infections at various vaccination coverage rates. by Albertus Constantijn Sloof (20405090)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: